01.04.2026

Batch recall – Tannosynt flüssig Konzentrat zur Herstellung einer Lösung zur Anwendung auf der Haut

Rückzug der Chargen 331432 und 528831 bis auf Stufe Detailhandel

01.04.2026

DHPC – Crysvita (Burosumab)

Risiko einer schweren Hyperkalzämie

01.04.2026

Out-of-Stock – Omjjara Filmtabletten

Befristete Bewilligung zum Vertrieb in tschechischer/polnischer/griechischer Aufmachung

01.04.2026

New: FAQs – Questions and answers on the risk management of human medicinal products

Swissmedic is supplementing its existing guidance documents with a structured collection of FAQs on key requirements and procedures relating to the risk management of human medicinal products

01.04.2026

Fassung 12.2 der Europäischen Pharmakopöe in Kraft

Der Institutsrat hat die Fassung 12.2 der Europäischen Pharmakopöe auf den 1. April 2026 in Kraft gesetzt

30.03.2026

The registration obligation for IVD devices in swissdamed replaces the notification obligation by 1st July 2026

The registration of devices according to Art. 90 IvDO will become mandatory in swissdamed as of July 1, 2026, with a transition period until December 31, 2026.

30.03.2026

The registration obligation for MD-DEVIT devices in swissdamed replaces the notification obligation by 1st July 2026

The registration of MD-DEVIT products according to Art. 108 MedDO will become mandatory in swissdamed as of July 1, 2026, with a transition period until December 31, 2026

30.03.2026

The registration obligation for MD devices in swissdamed replaces the notification obligation by 1st July 2026

The registration of devices, systems, and procedure packs according to Art. 108 MedDO will become mandatory in swissdamed as of July 1, 2026, with a transition period until December 31, 2026

In focus

Fillerbehandlungen

Filler Treatments

The video highlights the risks of not getting filler treatment from a specialist and explains how to reduce these risks. 

Contact for members of the public

Do you have any questions about a particular medicine or a general question about Swissmedic? We’ll be glad to be of assistance. 

Just send an e-mail to questions@swissmedic.ch or use our contact form. Thank you.

Direct links


Stay up to date


Reporting undesirable effects and incidents

Medicines


Medical devices

Swiss Public Assessment Report (SwissPAR)

SwissPAR

Summary report on authorisation

Featured


Swissmedic video portrait

Swissmedic monitors all therapeutic products on the market in Switzerland. Our independent experts ensure the therapeutic products you and your loved ones need are effective, safe and of the highest quality.

What is a medicinal product?

Did you know that tea can also be a medicinal product? But what exactly constitutes a medicinal product and how does it differ from other products? You will find answers to these and other questions in this video.

Delimitation questions in human health

In order for a product to be sold, it must comply with the relevant legal regulations. However, it’s not often immediately apparent which product group it belongs to. In this video, we explain what different categories there are, and when a product is really a therapeutic product – and when it is not!

Symbolbild_IVD

01.01.2025

New medical devices regulations

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

Revision of the IvDO and the MedDO
The transitional periods for in vitro diagnostic medical devices have been adapted to the EU Regulation and Swiss labelling simplifications remain unchanged. Information sheet Obligations Economic Operators CH (PDF, 1 MB, 20.03.2026) has been revised.
The device registration obligation will apply from 1 July 2026 (swissdamed)

swissmedic-teaser-mep-video1-anim

What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.


Swissmedic, Swiss Agency for Therapeutic Products

swissmedic_hauptsitz-hallerstrasse7-bern_03

Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...
https://www.swissmedic.ch/content/swissmedic/en/home.html